Ferreira-Neto AN, Puri R, Asmarats L, et al. Clinical and technical characteristics of coronary angiography and percutaneous coronary interventions performed before and after transcatheter aortic valve replacement with a balloon-expandable valve. J Interv Cardiol. 2019;2019:3579671. https://doi.org/10.1155/2019/3579671.
Article PubMed PubMed Central Google Scholar
Beach JM, Mihaljevic T, Svensson LG, et al. Coronary artery disease and outcomes of aortic-valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61(8):837–48. https://doi.org/10.1016/j.jacc.2012.10.049.
Article PubMed PubMed Central Google Scholar
Paradis JM, Fried J, Nazif T, et al. Aortic stenosis and coronary artery disease: what do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms. Eur Heart J. 2014;35(31):2069–82. https://doi.org/10.1093/eurheartj/ehu247.
Mazzone A, Venneri L, Berti S. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links. J Cardiovasc Med (Hagerstown). 2007;8(12):983–9. https://doi.org/10.2459/JCM.0b013e32802e6c3d.
El Sabbagh A, Nishimura RA. Clinical conundrum of coronary artery disease and aortic valve stenosis. J Am Heart Assoc. 2017. https://doi.org/10.1161/JAHA.117.005593.
Article PubMed PubMed Central Google Scholar
Perez S, Thielhelm TP, Cohen MG. To revascularize or not before transcatheter aortic-valve implantation? J Thorac Dis. 2018;10(Suppl 30):S3578–87. https://doi.org/10.21037/jtd.2018.09.85.
Article PubMed PubMed Central Google Scholar
Kodali SK, Moses JW. Coronary artery disease and aortic stenosis in the transcatheter aortic-valve replacement era: old questions, new paradigms: the evolving role of percutaneous coronary intervention in the treatment of patients with aortic stenosis. Circulation. 2012;125(8):975–7. https://doi.org/10.1161/CIRCULATIONAHA.111.087965.
Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease–implications for management in the transcatheter aortic-valve replacement era: a comprehensive review. J Am Coll Cardiol. 2013;62(1):1–10. https://doi.org/10.1016/j.jacc.2013.01.096.
Mori M, Gupta A, Wang Y, et al. Trends in Transcatheter and surgical aortic valve replacement among older adults in the United States. J Am Coll Cardiol. 2021;78(22):2161–72. https://doi.org/10.1016/j.jacc.2021.09.855.
Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol. 2018;71(12):1360–78. https://doi.org/10.1016/j.jacc.2018.01.057.
Jackson M, Williams PD. Coronary access following TAVI—Selective coronary engagement using balloon-assisted tracking of a guide catheter extension. Cardiovasc Revasc Med. 2018;19(3PtB):384–9. https://doi.org/10.1016/j.carrev.2017.07.015.
Persits I, Layoun H, Kondoleon NP, et al. Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic-valve replacement. Eur Heart J. 2024;45(21):1890–900. https://doi.org/10.1093/eurheartj/ehae019.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e25–197.
Patterson T, Clayton T, Dodd M, Khawaja Z, Morice MC, Wilson K, Kim WK, Meneveau N, Hambrecht R, Byrne J, Carrié D, Fraser D, Roberts DH, Doshi SN, Zaman A, Banning AP, Eltchaninoff H, Le Breton H, Smith D, Cox I, Frank D, Gershlick A, de Belder M, Thomas M, Hildick-Smith D, Prendergast B, Redwood S, ACTIVATION Trial Investigators. ACTIVATION (percutaneous coronary intervention prior to transcatheter aortic VAlve implantaTION): a randomized clinical trial. JACC Cardiovasc Interv. 2021;14(18):1965–74. https://doi.org/10.1016/j.jcin.2021.06.041.
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98. https://doi.org/10.1056/NEJMoa1103510.
Article CAS PubMed Google Scholar
Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic-valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63(19):1972–81. https://doi.org/10.1016/j.jacc.2014.02.556.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20. https://doi.org/10.1056/NEJMoa1514616.
Article CAS PubMed Google Scholar
Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31. https://doi.org/10.1056/NEJMoa1700456.
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705. https://doi.org/10.1056/NEJMoa1814052.
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15. https://doi.org/10.1056/NEJMoa1816885.
Hermiller JB Jr, Gunnarsson CL, Ryan MP, Moore KA, Clancy SJ, Irish W. The need for future coronary access following surgical or transcatheter aortic-valve replacement. Catheter Cardiovasc Interv. 2021;98(5):950–6. https://doi.org/10.1002/ccd.29841.
Elmariah S. Treatment of aortic stenosis by age in the US: evidence of institutional ageism. 2022
Coylewright M. Treatment of aortic stenosis by age in the US: Evidence of institutional ageism. 2022
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(3):362–72. https://doi.org/10.1016/j.jacc.2019.06.012.
Zivelonghi C, Pesarini G, Scarsini R, et al. Coronary catheterization and percutaneous interventions after transcatheter aortic valve implantation. Am J Cardiol. 2017;120(4):625–31. https://doi.org/10.1016/j.amjcard.2016.10.046.
Boukantar M, Gallet R, Mouillet G, et al. Coronary procedures after tavi with the self-expanding aortic bioprosthesis medtronic corevalve, not an easy matter. J Interv Cardiol. 2017;30(1):56–62. https://doi.org/10.1111/joic.12363.
Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol. 2015;104(8):632–9. https://doi.org/10.1007/s00392-015-0824-5.
Allali A, El-Mawardy M, Schwarz B, et al. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic-valve implantation with a self-expanding prosthesis. Results from a single center experience. Cardiovasc Revasc Med. 2016;17(6):391–8. https://doi.org/10.1016/j.carrev.2016.05.010.
Htun WW, Grines C, Schreiber T. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic-valve replacement using a Medtronic self-expandable bioprosthetic valve. Catheter Cardiovasc Interv. 2018;91(7):1339–44. https://doi.org/10.1002/ccd.27346.
Chakravarty T, Sharma R, Abramowitz Y, et al. Outcomes in patients with transcatheter aortic valve replacement and left main stenting: the TAVR-LM registry. J Am Coll Cardiol. 2016;67(8):951–60. https://doi.org/10.1016/j.jacc.2015.10.103.
Article PubMed PubMed Central Google Scholar
Tanaka A, Jabbour RJ, Testa L, et al. Incidence, technical safety, and feasibility of coronary angiography and intervention following self-expanding transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2019;20(5):371–5. https://doi.org/10.1016/j.carrev.2019.01.026.
Comments (0)